Drug shortage
Delayed Release · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · To Be Discontinued · updated Aug 13, 2026
Key facts
| Generic name | Delayed Release, Diclofenac Sodium Tablet |
|---|---|
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-06) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Musculoskeletal Rheumatology |
| Package NDCs | 0228-2550-06 |
| First posted | Aug 13, 2026 |
| Last updated | Aug 13, 2026 |
| Discontinued | Aug 13, 2026 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: